Apoptosome formation and caspase activation: Is it different in the heart?

Journal of Molecular and Cellular Cardiology

Volumn 37, Issue 3, 2004, Pages 643-652

  Czerski, Lech ^a   Nuñez, Gabriel ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apaf 1; Apoptosis; Apoptosome; ARC; Caspases

Indexed keywords

APOPTOTIC PROTEASE ACTIVATING FACTOR 1; CASPASE; CASPASE 9; CYSTEINE PROTEINASE; CYTOCHROME C; DEOXYADENOSINE TRIPHOSPHATE; PROTEIN BCL 2;

APOPTOSIS; BIOCHEMISTRY; CATALYSIS; CELL CYCLE; CELL DEATH; DNA DAMAGE; EMBRYO DEVELOPMENT; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME SYNTHESIS; HEART; HEART DISEASE; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HOMEOSTASIS; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MITOCHONDRION; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; APOPTOSIS; CASPASE 9; CASPASES; CYTOCHROMES C; HUMANS; MITOCHONDRIA, HEART; MULTIPROTEIN COMPLEXES; MYOCARDIAL ISCHEMIA; MYOCARDIUM; SIGNAL TRANSDUCTION;

EID: 3242730775     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.04.016     Document Type: Review

References (127)

1. Lockshin R.A., Williams C.M. Programmed cell death-I. Cytology of degeneration in the intersegmental muscles of the pernyi silkmoth. J Insect Physiol. 11:1965;123-133
2. Kerr J.F., Wyllie A.H., Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257
3. Wyllie A.H., Kerr J.F., Currie A.R. Cell death: the significance of apoptosis. Int Rev Cytol. 68:1980;251-306
4. Walker N.I., Harmon B.V., Gobe G.C., Kerr J.F. Patterns of cell death. Method Achiev Exp Pathol. 13:1988;18-54
5. Fawthrop D.J., Boobis A.R., Davies D.S. Mechanisms of cell death. Arch Toxicol. 65:1991;437-444
6. Vaux D.L. Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA. 90:1993;786-789
7. Ellis H.M., Horvitz H.R. Genetic control of programmed cell death in the nematode C. elegans. Cell. 44:1986;817-829
8. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell. 75:1993;641-652
9. Danial N.N., Korsmeyer S.J. Cell death: critical control points. Cell. 116:2004;205-219
10. Marsden V.S., Strasser A. Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol. 21:2003;71-105
11. Bouillet P., Strasser A. BH3-only proteins - evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci. 115:2002;1567-1574
12. Cohen G.M. Caspases: the executioners of apoptosis. Biochem J. 326:1997;1-16
13. Nicholson D.W. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ. 6:1999;1028-1042
14. Boatright K.M., Renatus M., Scott F.L., Sperandio S., Shin H., Pedersen I.M., et al. A unified model for apical caspase activation. Mol Cell. 2:2003;529-541
15. Riedl S.J., Fuentes-Prior P., Renatus M., Kairies N., Krapp S., Huber R., et al. Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci USA. 98:2001;14790-14795
16. Schweizer A., Briand C., Grutter M.G. Crystal structure of caspase-2, apical initiator of the intrinsic apoptotic pathway. J Biol Chem. 278:2003;42441-42447
17. Boatright K.M., Salvesen G.S. Mechanisms of caspase activation. Curr Opin Cell Biol. 15:2003;725-731
18. Stennicke H.R., Deveraux Q.L., Humke E.W., Reed J.C., Dixit V.M., Salvesen G.S. Caspase-9 can be activated without proteolytic processing. J Biol Chem. 274:1999;8359-8362
19. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell. 9:2002;459-470
20. Nagata S. Apoptosis by death factor. Cell. 88:1997;355-365
21. Ashkenazi A., Dixit V.M. Death receptors: signaling and modulation. Science. 281:1998;1305-1308
22. Chen G., Goeddel D.V. TNF-R1 signaling: a beautiful pathway. Science. 296:2002;1634-1635
23. Stennicke H.R., Jurgensmeier J.M., Shin H., Deveraux Q., Wolf B.B., Yang X., et al. Pro-caspase-3 is a major physiologic target of caspase-8. J Biol Chem. 273:1998;27084-27090
24. Salvesen G.S. Caspase 8: igniting the death machine. Struct Fold Des. 7:1999;225-229
25. Tsukumo S.I., Yonehara S. Requirement of cooperative functions of two repeated death effector domains in caspase-8 and in MC159 for induction and inhibition of apoptosis, respectively. Gene Cell. 4:1999;541-549
26. Muzio M., Stockwell B.R., Stennicke H.R., Salvesen G.S., Dixit V.M. An induced proximity model for caspase-8 activation. J Biol Chem. 273:1998;2926-2930
27. Chang D.W., Xing Z., Capacio V.L., Peter M.E., Yang X. Interdimer processing mechanism of procaspase-8 activation. EMBO J. 22:2003;4132-4142
28. Cortese J.D., Voglino A.L., Hackenbrock C.R. Multiple conformations of physiological membrane-bound cytochrome c. Biochemistry. 37:1998;6402-6409
29. Ott M., Robertson J.D., Gogvadze V., Zhivotovsky B., Orrenius S. Cytochrome c release from mitochondria proceeds by a two-step process. Proc Natl Acad Sci USA. 99:2002;1259-1263
30. Martinou J.C., Green D.R. Breaking the mitochondrial barrier. Nat Rev Mol Cell Biol. 2:2001;63-67
31. Jacotot E., Costantini P., Laboureau E., Zamzami N., Susin S.A., Kroemer G. Mitochondrial membrane permeabilization during the apoptotic process. Ann NY Acad Sci. 887:1999;18-30
32. Cheng E.H., Wei M.C., Weiler S., Flavell R.A., Mak T.W., Lindsten T., et al. BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol Cell. 8:2001;705-711
33. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 292:2001;727-730
34. Nomura M., Shimizu S., Ito T., Narita M., Matsuda H., Tsujimoto Y. Apoptotic cytosol facilitates Bax translocation to mitochondria that involves cytosolic factor regulated by Bcl-2. Cancer Res. 59:1999;5542-5548
35. Suzuki M., Youle R.J., Tjandra N. Structure of Bax: coregulation of dimer formation and intracellular localization. Cell. 103:2000;645-654
36. Zou H., Henzel W.J., Liu X., Lutschg A., Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell. 90:1997;405-413
37. Inohara N., Nunez G. The NOD: a signaling module that regulates apoptosis and host defense against pathogens. Oncogene. 20:2001;6473-6481
38. Inohara N., Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol. 3:2003;371-382
39. Hu Y., Ding L., Spencer D.M., Nunez G. WD-40 repeat region regulates Apaf-1 self-association and procaspase-9 activation. J Biol Chem. 273:1998;33489-33494
40. Hu Y., Benedict M.A., Ding L., Nunez G. Role of cytochrome c and dATP/ATP hydrolysis in Apaf-1-mediated caspase-9 activation and apoptosis. EMBO J. 18:1999;3586-3595
41. Cain K., Bratton S.B., Langlais C., Walker G., Brown D.G., Sun X.M., et al. Apaf-1 oligomerizes into biologically active approximately 700-kDa and inactive approximately 1.4-MDa apoptosome complexes. J Biol Chem. 275:2000;6067-6070
42. Purring-Koch C., McLendon G. Cytochrome c binding to Apaf-1: the effects of dATP and ionic strength. Proc Natl Acad Sci USA. 97:2000;11928-11931
43. Twiddy D., Brown D.G., Adrain C., Jukes R., Martin S.J., Cohen G.M., et al. Pro-apoptotic proteins released from the mitochondria regulate the protein composition and caspase-processing activity of the native Apaf-1/caspase-9 apoptosome complex. J Biol Chem. 279:2004;19665-19682
44. Liu X., Kim C.N., Yang J., Jemmerson R., Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:1996;147-157
45. Zou H., Li Y., Liu X., Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem. 274:1999;11549-11556
46. Cain K., Bratton S.B., Cohen G.M. The Apaf-1 apoptosome: a large caspase-activating complex. Biochimie. 84:2002;203-214
47. Jiang X., Wang X. Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem. 275:2000;31199-31203
48. Srinivasula S.M., Ahmad M., Fernandes-Alnemri T., Alnemri E.S. Autoactivation of procaspase-9 by Apaf-1-mediated oligomerization. Mol Cell. 1:1998;949-957
49. Rodriguez J., Lazebnik Y. Caspase-9 and APAF-1 form an active holoenzyme. Gene Dev. 13:1999;3179-3184
50. Acehan D., Jiang X., Morgan D.G., Heuser J.E., Wang X., Akey C.W. Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol Cell. 9:2002;423-432
51. Saleh A., Srinivasula S.M., Acharya S., Fishel R., Alnemri E.S. Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation. J Biol Chem. 274:1999;17941-17945
52. Chau B.N., Cheng E.H., Kerr D.A., Hardwick J.M. Aven, a novel inhibitor of caspase activation, binds Bcl-xL and Apaf-1. Mol Cell. 6:2000;31-40
53. Chu Z.L., Pio F., Xie Z., Welsh K., Krajewska M., Krajewski S., et al. A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J Biol Chem. 276:2001;9239-9245
54. Saleh A., Srinivasula S.M., Balkir L., Robbins P.D., Alnemri E.S. Negative regulation of the Apaf-1 apoptosome by Hsp70. Nat Cell Biol. 2:2000;476-483
55. Pandey P., Saleh A., Nakazawa A., Kumar S., Srinivasula S.M., Kumar V., et al. Negative regulation of cytochrome c-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90. EMBO J. 19:2000;4310-4322
56. Jiang X., Kim H.E., Shu H., Zhao Y., Zhang H., Kofron J., et al. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science. 299:2003;223-226
57. Salvesen G.S., Duckett C.S. IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol. 3:2002;401-410
58. Deveraux Q.L., Reed J.C. IAP family proteins - suppressors of apoptosis. Gene Dev. 13:1999;239-252
59. Riedl S.J., Renatus M., Schwarzenbacher R., Zhou Q., Sun C., Fesik S.W., et al. Structural basis for the inhibition of caspase-3 by XIAP. Cell. 104:2001;791-800
60. Chai J., Shiozaki E., Srinivasula S.M., Wu Q., Datta P., Alnemri E.S., et al. Structural basis of caspase-7 inhibition by XIAP. Cell. 104:2001;769-780
61. Shiozaki E.N., Chai J., Rigotti D.J., Riedl S.J., Li P., Srinivasula S.M., et al. Mechanism of XIAP-mediated inhibition of caspase-9. Mol Cell. 11:2003;519-527
62. Du C., Fang M., Li Y., Li L., Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell. 102:2000;33-42
63. Verhagen A.M., Ekert P.G., Pakusch M., Silke J., Connolly L.M., Reid G.E., et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell. 102:2000;43-53
64. Wu G., Chai J., Suber T.L., Wu J.W., Du C., Wang X., et al. Structural basis of IAP recognition by Smac/DIABLO. Nature. 408:2000;1008-1012
65. Liu Z., Sun C., Olejniczak E.T., Meadows R.P., Betz S.F., Oost T., et al. Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain. Nature. 408:2000;1004-1008
66. Scheubel R.J., Bartling B., Simm A., Silber R.E., Drogaris K., Darmer D., et al. Apoptotic pathway activation from mitochondria and death receptors without caspase-3 cleavage in failing human myocardium: fragile balance of myocyte survival? J Am Coll Cardiol. 39:2002;481-488
67. Yoshida H., Kong Y.Y., Yoshida R., Elia A.J., Hakem A., Hakem R., et al. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell. 94:1998;739-750
68. Cecconi F., Alvarez-Bolado G., Meyer B.I., Roth K.A., Gruss P. Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian development. Cell. 94:1998;727-737
69. Marsden V.S., O'Connor L., O'Reilly L.A., Silke J., Metcalf D., Ekert P.G., et al. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature. 419:2002;634-637
70. Huang D.C., Strasser A. BH3-only proteins-essential initiators of apoptotic cell death. Cell. 103:2000;839-842
71. Suzuki Y., Imai Y., Nakayama H., Takahashi K., Takio K., Takahashi R. A serine protease, HtrA2, is released from the mitochondria and interacts with XIAP, inducing cell death. Mol Cell. 8:2001;613-621
72. Penninger J.M., Kroemer G. Mitochondria, AIF and caspases - rivaling for cell death execution. Nat Cell Biol. 5:2003;97-99
73. Li L.Y., Luo X., Wang X. Endonuclease G is an apoptotic DNase when released from mitochondria. Nature. 412:2001;95-99
74. Wolter K.G., Hsu Y.T., Smith C.L., Nechushtan A., Xi X.G., Youle R.J. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol. 139:1997;1281-1292
75. Muchmore S.W., Sattler M., Liang H., Meadows R.P., Harlan J.E., Yoon H.S., et al. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 381:1996;335-341
76. Kuwana T., Mackey M.R., Perkins G., Ellisman M.H., Latterich M., Schneiter R., et al. Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell. 111:2002;331-342
77. Yethon J.A., Epand R.F., Leber B., Epand R.M., Andrews D.W. Interaction with a membrane surface triggers a reversible conformational change in Bax normally associated with induction of apoptosis. J Biol Chem. 278:2003;48935-48941
78. Narita M., Shimizu S., Ito T., Chittenden T., Lutz R.J., Matsuda H., et al. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA. 95:1998;14681-14686
79. Green D.R., Evan G.I. A matter of life and death. Cancer Cell. 1:2002;19-30
80. Rao R.V., Hermel E., Castro-Obregon S., del Rio G., Ellerby L.M., Ellerby H.M., et al. Coupling endoplasmic reticulum stress to the cell death program. Mechanism of caspase activation. J Biol Chem. 276:2001;33869-33874
81. 2+: a control point for apoptosis. Science. 300:2003;135-139
82. Zong W.X., Li C., Hatzivassiliou G., Lindsten T., Yu Q.C., Yuan J., et al. Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol. 162:2003;59-69
83. Nakagawa T., Yuan J. Cross-talk between two cysteine protease families. Activation of caspase-12 by calpain in apoptosis. J Cell Biol. 150:2000;887-894
84. Rao R.V., Castro-Obregon S., Frankowski H., Schuler M., Stoka V., del Rio G., et al. Coupling endoplasmic reticulum stress to the cell death program. An Apaf-1-independent intrinsic pathway. J Biol Chem. 277:2002;21836-21842
85. Morishima N., Nakanishi K., Takenouchi H., Shibata T., Yasuhiko Y. An endoplasmic reticulum stress-specific caspase cascade in apoptosis. Cytochrome c-independent activation of caspase-9 by caspase-12. J Biol Chem. 277:2002;34287-34294
86. Breckenridge D.G., Germain M., Mathai J.P., Nguyen M., Shore G.C. Regulation of apoptosis by endoplasmic reticulum pathways. Oncogene. 22:2003;8608-8618
87. Nakagawa T., Zhu H., Morishima N., Li E., Xu J., Yankner B.A., et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature. 403:2000;98-103
88. Fischer H., Koenig U., Eckhart L., Tschachler E. Human caspase 12 has acquired deleterious mutations. Biochem Biophys Res Commun. 293:2002;722-726
89. Gill C., Mestril R., Samali A. Losing heart: the role of apoptosis in heart disease - a novel therapeutic target? FASEB J. 16:2002;135-146
90. Abbate A., Biondi-Zoccai G.G., Baldi A. Pathophysiologic role of myocardial apoptosis in post-infarction left ventricular remodeling. J Cell Physiol. 193:2002;145-153
91. Rodriguez M., Lucchesi B.R., Schaper J. Apoptosis in myocardial infarction. Ann Med. 34:2002;470-479
92. Kang P.M., Yue P., Izumo S. New insights into the role of apoptosis in cardiovascular disease. Circ J. 66:2002;1-9
93. Borutaite V., Brown G.C. Mitochondria in apoptosis of ischemic heart. FEBS Lett. 541:2003;1-5
94. Clerk A., Cole S.M., Cullingford T.E., Harrison J.G., Jormakka M., Valks D.M. Regulation of cardiac myocyte cell death. Pharmacol Ther. 97:2003;223-261
95. Tatsumi T., Shiraishi J., Keira N., Akashi K., Mano A., Yamanaka S., et al. Intracellular ATP is required for mitochondrial apoptotic pathways in isolated hypoxic rat cardiac myocytes. Cardiovasc Res. 59:2003;428-440
96. Saraste A., Pulkki K., Kallajoki M., Henriksen K., Parvinen M., Voipio-Pulkki L.M. Apoptosis in human acute myocardial infarction. Circulation. 95:1997;320-323
97. Freude B., Masters T.N., Robicsek F., Fokin A., Kostin S., Zimmermann R., et al. Apoptosis is initiated by myocardial ischemia and executed during reperfusion. J Mol Cell Cardiol. 32:2000;197-208
98. Kang P.M., Haunstetter A., Aoki H., Usheva A., Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res. 87:2000;118-125
99. von Harsdorf R., Li P.F., Dietz R. Signaling pathways in reactive oxygen species-induced cardiomyocyte apoptosis. Circulation. 99:1999;2934-2941
100. Yaoita H., Ogawa K., Maehara K., Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor. Circulation. 97:1998;276-281
101. Laugwitz K.L., Moretti A., Weig H.J., Gillitzer A., Pinkernell K., Ott T., et al. Blocking caspase-activated apoptosis improves contractility in failing myocardium. Hum Gene Ther. 12:2001;2051-2063
102. Kang P.M., Izumo S. Apoptosis in heart failure: is there light at the end of the tunnel (TUNEL)? J Card Fail. 6:2000;43-46
103. Wencker D., Chandra M., Nguyen K., Miao W., Garantziotis S., Factor S.M., et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J Clin Invest. 111:2003;1497-1504
104. Ishiyama S., Hiroe M., Nishikawa T., Shimojo T., Abe S., Fujisaki H., et al. The Fas/Fas ligand system is involved in the pathogenesis of autoimmune myocarditis in rats. J Immunol. 161:1998;4695-4701
105. Lee P., Sata M., Lefer D.J., Factor S.M., Walsh K., Kitsis R.N. Fas pathway is a critical mediator of cardiac myocyte death and MI during ischemia-reperfusion in vivo. Am J Physiol Heart Circ Physiol. 284:2003;456-463
106. Kubota T., McTiernan C.F., Frye C.S., Slawson S.E., Lemster B.H., Koretsky A.P., et al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res. 81:1997;627-635
107. de Jonge N., van Wichen D.F., van Kuik J., Kirkels H., Lahpor J.R., Gmelig-Meyling F.H., et al. Cardiomyocyte death in patients with end-stage heart failure before and after support with a left ventricular assist device: low incidence of apoptosis despite ubiquitous mediators. J Heart Lung Transplant. 22:2003;1028-1036
108. Imanishi T., Murry C.E., Reinecke H., Hano T., Nishio I., Liles W.C., et al. Cellular FLIP is expressed in cardiomyocytes and down-regulated in TUNEL-positive grafted cardiac tissues. Cardiovasc Res. 48:2000;101-110
109. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., et al. Inhibition of death receptor signals by cellular FLIP. Nature. 388:1997;190-195
110. Kataoka T., Schroter M., Hahne M., Schneider P., Irmler M., Thome M., et al. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation. J Immunol. 161:1998;3936-3942
111. Yeh W.C., Pompa J.L., McCurrach M.E., Shu H.B., Elia A.J., Shahinian A., et al. FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science. 279:1998;1954-1958
112. Bialik S., Cryns V.L., Drincic A., Miyata S., Wollowick A.L., Srinivasan A., et al. The mitochondrial apoptotic pathway is activated by serum and glucose deprivation in cardiac myocytes. Circ Res. 85:1999;403-414
113. Malhotra R., Brosius F.C. III. Glucose uptake and glycolysis reduce hypoxia-induced apoptosis in cultured neonatal rat cardiac myocytes. J Biol Chem. 274:1999;12567-12575
114. Kang P.M., Haunstetter A., Aoki H., Usheva A., Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res. 87:2000;118-125
115. de Moissac D., Gurevich R.M., Zheng H., Singal P.K., Kirshenbaum L.A. Caspase activation and mitochondrial cytochrome c release during hypoxia-mediated apoptosis of adult ventricular myocytes. J Mol Cell Cardiol. 32:2000;53-63
116. Kang P.M., Haunstetter A., Aoki H., Usheva A., Izumo S. Morphological and molecular characterization of adult cardiomyocyte apoptosis during hypoxia and reoxygenation. Circ Res. 87:2000;118-125
117. Baldi A., Abbate A., Bussani R., Patti G., Melfi R., Angelini A., et al. Apoptosis and post-infarction left ventricular remodeling. J Mol Cell Cardiol. 34:2002;165-174
118. Mocanu M.M., Baxter G.F., Yellon D.M. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol. 130:2000;197-200
119. Perrin C., Ecarnot-Laubriet A., Vergely C., Rochette L. Calpain and caspase-3 inhibitors reduce infarct size and post-ischemic apoptosis in rat heart without modifying contractile recovery. Cell Mol Biol. 49:2003;497-505
120. Brocheriou V., Hagege A.A., Oubenaissa A., Lambert M., Mallet V.O., Duriez M., et al. Cardiac functional improvement by a human Bcl-2 transgene in a mouse model of ischemia/reperfusion injury. J Gene Med. 2:2000;326-333
121. Burgess D.H., Svensson M., Dandrea T., Gronlund K., Hammarquist F., Orrenius S., et al. Human skeletal muscle cytosols are refractory to cytochrome c-dependent activation of type-II caspases and lack APAF-1. Cell Death Differ. 6:1999;256-261
122. Koseki T., Inohara N., Chen S., Nunez G. ARC, an inhibitor of apoptosis expressed in skeletal muscle and heart that interacts selectively with caspases. Proc Natl Acad Sci USA. 95:1998;5156-5160
123. Ekhterae D., Lin Z., Lundberg M.S., Crow M.T., Brosius F.C. III, Nunez G. ARC inhibits cytochrome c release from mitochondria and protects against hypoxia-induced apoptosis in heart-derived H9c2 cells. Circ Res. 85:1999;e70-e77
124. Neuss M., Monticone R., Lundberg M.S., Chesley A.T., Fleck E., Crow M.T. The apoptotic regulatory protein ARC (apoptosis repressor with caspase recruitment domain) prevents oxidant stress-mediated cell death by preserving mitochondrial function. J Biol Chem. 276:2001;33915-33922
125. Li P.F., Li J., Muller E.C., Otto A., Dietz R., von Harsdorf R. Phosphorylation by protein kinase CK2: a signaling switch for the caspase-inhibiting protein ARC. Mol Cell. 10:2002;247-258
126. Gustafsson A.B., Sayen M.R., Williams S.D., Crow M.T., Gottlieb R.A. TAT protein transduction into isolated perfused hearts: TAT-apoptosis repressor with caspase recruitment domain is cardioprotective. Circulation. 106:2002;735-739
127. Chatterjee S., Bish L.T., Jayasankar V., Stewart A.S., Woo Y.J., Crow M.T., et al. Blocking the development of postischemic cardiomyopathy with viral gene transfer of the apoptosis repressor with caspase recruitment domain. J Thorac Cardiovasc Surg. 125:2003;1461-1469